原发性干燥综合征临床试验中唇腺组织病理学的标准化
Labial salivary gland (LSG) biopsy is used in the classification of primary Sjögren's syndrome (PSS) and in patient stratification in clinical trials. It may also function as a biomarker.…
要点
- 共识聚焦唇腺活检组织要求、灶性淋巴细胞性涎腺炎识别及灶评分计算等16项要点。
- 标准化的唇腺组织病理学可用于PSS分类和临床试验中的患者分层及生物标志物应用。
核心结论
- 提供了唇腺组织病理学在PSS分类和临床试验中使用的标准化共识指导,并识别了需进一步研究以实现循证共识的领域。
研究设计与样本
- 采用改良的欧洲抗风湿病联盟(EULAR)共识指南制定策略,由特设工作组指导委员会识别唇腺获取与分析的关键变异点,经两日工作会议制定共识,再由PSS组织病理学专家 subgroup 审核,并通过在线调查对50名利益相关专家(风湿科医生、组织病理学家和口腔医学专家)评估同意程度。
主要发现
- 共识要点聚焦于组织要求、特征性灶性淋巴细胞性涎腺炎的识别、灶评分计算、生发中心识别、白细胞浸润面积评估、报告标准以及临床试验中预研究样本的使用。
关键数值与推荐
- 同意标准为平均评分≥6/10且75%的受访者评分≥6/10。
- 16个要点达到同意标准,涉及组织要求、灶性淋巴细胞性涎腺炎识别、灶评分计算、生发中心识别、白细胞浸润面积评估、报告标准和预研究样本使用。
临床怎么用
- 在PSS分类和临床试验中,唇腺活检的组织获取与组织学判读应遵循本共识的标准化要点,以减少变异并支持患者分层和生物标志物应用。
局限性
- 文中指出在达成循证共识方面仍需进一步研究,但未具体列出局限性细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Labial salivary gland (LSG) biopsy is used in the classification of primary Sjögren's syndrome (PSS) and in patient stratification in clinical trials. It may also function as a biomarker. The acquisition of tissue and histological interpretation is variable and needs to be standardised for use in clinical trials. A modified European League Against Rheumatism consensus guideline development strategy was used. The steering committee of the ad hoc working group identified key outstanding points of variability in LSG acquisition and analysis. A 2-day workshop was held to develop consensus where possible and identify points where further discussion/data was needed. These points were reviewed by a subgroup of experts on PSS histopathology and then circulated via an online survey to 50 stakeholder experts consisting of rheumatologists, histopathologists and oral medicine specialists, to assess level of agreement (0-10 scale) and comments. Criteria for agreement were a mean score ≥6/10 and 75% of respondents scoring ≥6/10. Thirty-nine (78%) experts responded and 16 points met criteria for agreement. These points are focused on tissue requirements, identification of the characteristic focal lymphocytic sialadenitis, calculation of the focus score, identification of germinal centres, assessment of the area of leucocyte infiltration, reporting standards and use of prestudy samples for clinical trials. We provide standardised consensus guidance for the use of labial salivary gland histopathology in the classification of PSS and in clinical trials and identify areas where further research is required to achieve evidence-based consensus.
引用
- Fisher BA, Jonsson R, Daniels T, et al. Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome. Ann Rheum Dis. 2016. PMID: 27965259. doi:10.1136/annrheumdis-2016-210448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。